UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.06 +0.06 (+0.08%) GOLD FUTURES
2,313.40 +2.40 (+0.10%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,259.00 +1,082.73 (+2.34%)
Virpax Pharmaceuticals, Inc. (VRPX)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Loading interactive chart…
- Business Wire
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
BERWYN, Pa., April 30, 2024--Virpax Announces Results of MTD Study for Probudur. Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief
- Business Wire
Virpax Pharmaceuticals Reports 2023 Year-End Results
BERWYN, Pa., March 26, 2024--Virpax Reports 2023 Year-End Results
- Business Wire
Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
BERWYN, Pa., February 27, 2024--Virpax Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
© 2024 Yahoo. All rights reserved.